HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thrombolytic effect after sequential double-bolus administration of tissue plasminogen activator and urokinase-fibrinogen conjugate into dogs with venous thrombosis.

AuthorsA V Maksimenko, E G Tischenko, V L Golubykh
JournalAnnals of the New York Academy of Sciences (Ann N Y Acad Sci) Vol. 864 Pg. 409-17 (Dec 13 1998) ISSN: 0077-8923 [Print] United States
PMID9928118 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Fibrinolytic Agents
  • Recombinant Proteins
  • urokinase-fibrinogen conjugate
  • Fibrinogen
  • Tissue Plasminogen Activator
  • Urokinase-Type Plasminogen Activator
Topics
  • Animals
  • Dogs
  • Drug Therapy, Combination
  • Fibrinogen (administration & dosage, analogs & derivatives, therapeutic use)
  • Fibrinolysis
  • Fibrinolytic Agents (administration & dosage, therapeutic use)
  • Humans
  • Injections, Intravenous
  • Recombinant Proteins (administration & dosage, therapeutic use)
  • Tissue Plasminogen Activator (administration & dosage, therapeutic use)
  • Urokinase-Type Plasminogen Activator (administration & dosage, therapeutic use)
  • Venous Thrombosis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: